AnalystsAndreas ArgyridesAndreas Argyrides's Stock Forecasts
AnalystsAndreas Argyrides
Sectors:
Analyst Ranking
Top 34%
#1404 out of 4174 analysts
Average Return
+7.9%
Win Rate
71%5 out of 7
Risk vs Reward
Poor
Good
Andreas Argyrides's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Albireo Pharma IncALBO | +142.53% | $18.08 | $43.85 | 2022-08-15 - 2023-01-09 | Buy |
Immunic IncIMUX | +8.75% | $2.40 | $2.61 | 2023-01-30 - 2023-02-06 | Buy |
Pacira Biosciences IncPCRX | +5.02% | $39.27 | $41.24 | 2023-01-30 - 2023-02-06 | Buy |
Ascendis Pharma AASND | +3.53% | $110.26 | $114.15 | 2022-11-13 - 2023-02-06 | Buy |
Ars Pharmaceuticals IncSPRY | +2.19% | $6.86 | $7.01 | 2023-01-30 - 2023-02-06 | Buy |
Andreas Argyrides Analyst Color
Get additional color on Andreas Argyrides's coverage of popular stocks
Andreas Argyrides's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pacira Biosciences IncPCRX | 1 | Buy | $60.00 | +45.49% | Assumes | 7 days ago |
Ars Pharmaceuticals IncSPRY | 1 | Buy | $10.00 | +42.65% | Initiates Coverage On | 7 days ago |
Immunic IncIMUX | 1 | Buy | $5.00 | +91.57% | Assumes | 7 days ago |
Biomarin Pharmaceutical IncBMRN | 2 | Hold | $83.00 | -26.01% | Maintains | a month ago |
Albireo Pharma IncALBO | 2 | Hold | $42.00 | -5.81% | Downgrades | a month ago |
Ascendis Pharma AASND | 1 | Buy | $164.00 | +43.67% | Maintains | 3 months ago |
Gossamer Bio IncGOSS | 1 | Buy | $24.00 | +779.12% | Initiates Coverage On | 5 months ago |
Global Blood Therapeutics IncGBT | 1 | Hold | N/A | N/A | Downgrades | 6 months ago |
Sangamo Therapeutics IncSGMO | 1 | Hold | $5.00 | +44.51% | Assumes | 8 months ago |
Rani Therapeutics Holdings IncRANI | 1 | Buy | $28.00 | +378.63% | Initiates Coverage On | 8 months ago |
Regenxbio IncRGNX | 1 | Hold | $29.00 | N/A | Initiates Coverage On | a year ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.